Trial Profile
A Prospective, Randomized, Single-blind Study to Compare the Effects of Daily Ulipristal Acetate (UPA) 10mg With a Combined Oral Contraceptive (COC) Pill on Breast Epithelial Cell Proliferation in Reproductive Age Women
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Apr 2022
Price :
$35
*
At a glance
- Drugs Ulipristal (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Breast cancer
- Focus Therapeutic Use
- 01 Apr 2022 Results published in the Breast Cancer Research and Treatment
- 05 Feb 2020 Status changed from recruiting to completed.
- 06 Feb 2017 Status changed from not yet recruiting to recruiting.